Wearable device company deploys repeatable use cases across multiple clients and market segments by relying on a fully managed, data integration solution from Lyniate.
BioIntelliSense provides medical-grade continuous health monitoring and COVID-19 screening at scale. Their proprietary FDA-cleared BioSticker™ and medical-grade BioButton™ wearable devices and algorithmic data services provide clinical intelligence that sets a new standard in Remote Patient Monitoring (RPM).
When the COVID-19 pandemic spread, BioIntelliSense accelerated the development and launch of its COVID-19 solution to screen patients for signs and symptoms of an early infectious process for the safe return to work, school, travel, and events. Building Lyniate into the BioIntelliSense platform architecture from the beginning empowered them to pivot quickly across multiple clients and market segments.
Leveraging proven integration capabilities and expertise from Lyniate, BioIntelliSense enabled medical grade care at home by successfully integrating with a leading EHR’s environment, more than 20 best-in-class RPM applications, and telehealth solutions.
BioIntelliSense originally selected Lyniate for integration of JSON device data into Epic EHR via HL7 for a leading healthcare system in Colorado.
In this case study, learn how BioIntelliSense addresses every data integration challenge with Lyniate Envoy a fully managed integration solution.